Home

Some companies that have chosen us

Privacy Officer and Privacy Consultant
CDP Scheme according to ISO/IEC 17024:2012
European Privacy Auditor
ISDP©10003 Certification Scheme according to ISO/IEC 17065:2012
Auditor
According to standard UNI 11697:2017
Lead Auditor ISO/IEC 27001:2022
According to standard ISO/IEC 17024:2012
Data Protection Officer
According to standard ISO/IEC 17024:2012
Anti-Bribery Lead Auditor Expert
According to standard ISO/IEC 17024:2012
ICT Security Manager
According to standard UNI 11506:2017
IT Service Management (ITSM)
According to the ITIL Foundation
Ethical Hacker (CEH)
According to the EC-Council
Network Defender (CND)
According to the EC-Council
Computer Hacking Forensics Investigator (CHFI)
According to the EC-Council
Penetration Testing Professional (CPENT)
According to the EC-Council

Professional qualifications

Stay up-to-date with world news!

Select your topics of interest:

News

Home / News
/
FRENCH SUPERVISORY AUTHORITY: CNIL publishes interim recommendations for quality control of clinical trials during the health crisis

FRENCH SUPERVISORY AUTHORITY: CNIL publishes interim recommendations for quality control of clinical trials during the health crisis

The current health crisis can make difficult carry out the control of the quality of clinical experimentations in investigation centers. In order to facilitate those controls, the CNIL publishes recommendations which are valid until a month after the health emergency status.

The quality control (or control) consist in verifying the integrity and the accuracy of data shared by investigation center to the promotor (the person or the responsible body of the performance of the research), in order to guarantee the reliability of results. Usually it takes place in the center in which the patient is witnessed and is carried out under the supervision of the investigation team.

Quality control may in particular consist in verifying, by a “clinical researcher” (ARC) on behalf of the sponsor, the source documents (clinical records, laboratory analysis reports, etc.) Compared to the data collected in the notebook of observation by the investigator.

The problems encountered

Due to the constraints of the health situation, clinical research associates (ARC) can no longer, for some trials, go to the investigation centers to access the clinical records of the research participants.

Solutions must therefore be found to provide for remote quality control in certain cases, ensuring the protection of the data of the patients concerned.

CNIL recommendations

The CNIL recommendations are temporary (limited to 1 month after the end of the state of health emergency):

These recommendations shall specify in particular:

  • the scope of the clinical trials concerned in accordance with European guidelines drawn up by health agencies;
  • CNIL formalities and exceptions
  • the information of the persons concerned;
  • the general conditions to be observed;
  • possible technical solutions and associated safety conditions.

The National Commission for Human Involvement Research (CNRIPH) and the National Agency for the Safety of Medicines and Health Products (ANSM) were also consulted on these recommendations.

SOURCE: AUTORITA’ PER LA PROTEZIONE DEI DATI DELLA FRANCIA – CNIL

Recommended to you

Advanced Research